Using REMBRANDT to Paint in the Details of Glioma Biology: Applications for Future Immunotherapy

  title={Using REMBRANDT to Paint in the Details of Glioma Biology: Applications for Future Immunotherapy},
  author={A. Dang and Neil Hoa and L. Ge and G. A. Morillo and Brian J Paleo and E. J. G{\'o}mez and D. J. Shon and Erin Hong and Ahmed M. Aref and M. Jadus},
  • A. Dang, Neil Hoa, +7 authors M. Jadus
  • Published 2013
  • Biology
  • Microarray technology developed in the late 1990’s allows one to simultaneously analyze the entire transcriptome of a given population of cells at a single time. It is essentially a microchip with each spot containing about a picogram of DNA immobilized at defined locations. This DNA captures mRNA or cDNA from defined cell populations (tissue, cell line, etc) in a quantitative manner. This technique allows complex patterns of global gene expressions to be quickly and easily detected between two… CONTINUE READING
    7 Citations

    Figures and Tables from this paper.

    Temozolomide induces the expression of the glioma Big Potassium (gBK) ion channel, while inhibiting fascin-1 expression: possible targets for glioma therapy
    • 5
    Small cell lung cancer cells express the late stage gBK tumor antigen: a possible immunotarget for the terminal disease.
    • 10
    Fascin-1 knock-down of human glioma cells reduces their microvilli/filopodia while improving their susceptibility to lymphocyte-mediated cytotoxicity.
    • N. Hoa, L. Ge, +6 authors M. Jadus
    • Biology, Medicine
    • American journal of translational research
    • 2015
    • 9
    • PDF
    Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle.
    • 35
    • Highly Influenced
    Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy.
    • 43


    γδ T cells as immune effectors against high-grade gliomas
    • L. Lamb
    • Biology, Medicine
    • Immunologic research
    • 2009
    • 17
    γδ T cells as immune effectors against high-grade gliomas
    • 13
    T-cell immunotherapy for malignant glioma: toward a combined approach
    • 24
    A multigene predictor of outcome in glioblastoma.
    • 315
    • PDF
    Identification of midkine as a mediator for intercellular transfer of drug resistance
    • 75
    • PDF
    Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
    • 8,872
    • PDF
    The role of myosin II in glioma invasion of the brain.
    • 282
    Mechanisms of malignant glioma immune resistance and sources of immunosuppression.
    • 131
    • PDF
    Microarray Analysis Verifies Two Distinct Phenotypes of Glioblastomas Resistant to Antiangiogenic Therapy
    • 93
    • PDF